A recent alert issued by the Directorate of Drugs Control, Punjab, highlights serious concerns about using intravenous (IV) ceftriaxone with calcium-containing products, such as Ringer Lactate. This alert is based on reports of adverse drug reactions and underscores the risk of IV admixture incompatibility. Healthcare professionals are advised to take immediate action to ensure patient safety. Details of the Alert Issued By: Punjab Pharmacovigilance Center Key Concern Using IV ceftriaxone and calcium-containing products together can cause severe, potentially fatal complications due to precipitation in the bloodstream. This issue is particularly critical in neonates but extends to older infants and adults under specific conditions. Pharmacovigilance Center Findings The Pharmacovigilance Center in Punjab has reported numerous adverse reactions related to the combined use of IV ceftriaxone and calcium-containing products. Investigations revealed: ...
BSN at College of Nursing NICH: A Success Story Needed to be Replicated in Public Sector Nursing Institutes
By: Shabir Hussain The College of Nursing, National Institute of Child Health (CON-NICH), has achieved a remarkable milestone by becoming the first institute under Health Department Sindh to complete 04-Yr Nursing Degree Program with thumping success. Not only did it complete the course on time, but also excelled in education, training, and professionalism at par with other best nursing colleges of Sindh. It is noteworthy that in 2019, when PNMC,the Federal and Provincial Governments phased out the Three-Year General Nursing Diploma and introduced a four-year degree program, all colleges under provincial government management across the country lagged behind by one year without induction. However, Nursing College NICH stood out, achieving the first admission in year 2020. Their first batch of BSN had achieved a 100% passing rate and commenced one year internship. They are now conducting Evidence-Based seminars on final research papers of the second batch of Semester VIII. The...